Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Point-of-Care (POC) Coagulation Testing Market Size Likely To Evolve From 2025 Through 2034?
Strong expansion has characterized the point-of-care (poc) coagulation testing market recently, projecting a rise from a valuation of $1.18 billion in 2024 to $1.25 billion in 2025, which corresponds to a compound annual growth rate (CAGR) of 5.4%; this upward trajectory throughout the historical period is traceable to several factors including increasing patient requirements, the burgeoning adoption of testing conducted at the patient’s site, the high degree of trustworthiness associated with assessing coagulation status via the prothrombin time (pt) test, advancements in automation and incorporation with electronic health records (EHRs), alongside a greater prevalence of cardiovascular illnesses and various blood-related conditions.
Forecasting a consistent upward trajectory, the market valuation for point-of-care (poc) coagulation testing is projected to reach $1.47 billion by 2029, reflecting a compound annual growth rate (CAGR) of 4.2%; this expansion across the prediction window is driven by several key factors, including the proliferation of testing in broader healthcare contexts, escalating needs within home care environments, a higher incidence of persistent blood-related conditions among the population, an increased desire from patients for swift and precise diagnostic results, and the general surge in demand for immediate testing solutions at the patient’s location, while dominant trends shaping this period encompass innovations in technology, substantial demand originating from industrialized nations, continuous broadening of healthcare utility, the lingering effects of the COVID-19 pandemic, and the progression toward diagnostics capable of handling multiple targets simultaneously within a poc framework.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp
Which Drivers Are Impacting The Point-of-Care (POC) Coagulation Testing Market?
An escalation in the prevalence of heart and blood vessel disorders, encompassing issues like coronary, cerebrovascular, and peripheral arterial conditions, is anticipated to fuel the expansion of the point-of-care (POC) coagulation testing sector in the foreseeable future. This particular type of decentralized testing proves beneficial for managing cardiovascular ailments (CVDs) because it furnishes immediate insights into a patient’s current coagulation state, thereby facilitating prompt choices regarding necessary interventions related to blood clotting and subsequently mitigating the chances of excessive bleeding following heart procedures. To illustrate this trend, data released in October 2022 by the World Heart Federation, an NGO based in Switzerland, projected a worsening mortality rate due to CVDs, forecasting that deaths associated with these conditions would climb from roughly 18.9 million fatalities in 2020 to surpass 22.2 million by the year 2030, eventually reaching a figure of 32.3 million per year by 2050; consequently, this documented surge in cardiovascular disease cases is acting as a stimulant for the expansion of the market for POC coagulation testing devices.
What Are The Major Segment Categories Driving The Point-of-Care (POC) Coagulation Testing Market Growth?
The point-of-care (poc) coagulation testingmarket covered in this report is segmented –
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care
Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection
Which Ongoing Trends Are Expected To Shape The Point-of-Care (POC) Coagulation Testing Market Outlook?
Key players within the point-of-care (POC) coagulation testing sector are prioritizing tactical alliances as a method to enhance their standing in the marketplace. Such a strategic partnership involves a structured pact among distinct entities to pursue shared, established objectives that yield reciprocal advantages. An illustration of this occurred in January 2023, when Jana care, an American firm specializing in biomarker assays for its unique digital health system, entered into an agreement with Roche Diagnostics, a Swiss entity renowned for engineering diagnostic tools, machinery, and digital health innovations intended to revolutionize patient care. The objective of this joint venture is the creation and rollout of a home-use blood testing system intended for the preliminary identification of both chronic kidney ailments and cardiac insufficiency, allowing individuals to conduct the necessary blood analyses in their residences, with professional healthcare providers subsequently examining the outcomes off-site.
Who Are The Primary Competitors In The Global Point-of-Care (POC) Coagulation Testing Market?
Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Point-of-Care (POC) Coagulation Testing Industry?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Point-of-Care (POC) Coagulation Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp
Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Market 2025, By The Business Research Company
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2025
Implantable Drug Delivery Devices Global Market Report 2025
Implantable Infusion Pumps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model